O’Brien Medical Launches New Instrument for Diabetes Market

December 6, 2017 |

1 min read

Now clinicians can implement a standardized approach for diagnosing diabetic peripheral neuropathy utilizing the three most popular frequencies in medicine.

O’Brien Medical announces launch of second product, the ETFMx.

[06-December-2017]

ORONO, Maine, Dec. 6, 2017 /PRNewswire/ -- O’Brien Medical is pleased to announce the official launch of the ETFMx multi-frequency electronic tuning fork. Building on the success of the base model ETF128, the Mx takes quantitative sensation testing to the next level. Now clinicians can implement a standardized approach for diagnosing diabetic peripheral neuropathy utilizing the three most popular frequencies in medicine. This multi-frequency instrument saves time and money by essentially integrating three tuning forks into one. The Mx will be sold exclusively through the company’s website and select distribution partners.

About O’Brien Medical
O’Brien Medical is a medical device startup engaged in the development of point-of-care neurodiagnostic instruments. Inquiries may be forwarded to tobrien@obimed.com.

View original content with multimedia:http://www.prnewswire.com/news-releases/obrien-medical-launches-new-instrument-for-diabetes-market-300567225.html

SOURCE O’Brien Medical

Medtech Medical device